Skip to content
Middletown Life
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Spero Therapeutics, Inc.
Spero Therapeutics Appoints William Ho, M.D., Ph.D., to its Board of Directors
November 10, 2026
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 4, 2026
Spero Therapeutics to Present at Investor Conferences in November
November 2, 2026
Spero Therapeutics Strengthens Leadership Team to Advance Immunology Pipeline
October 26, 2026
Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
October 15, 2026
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2026
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 3, 2026
Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
September 2, 2026
Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update
August 12, 2026
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 6, 2026
1
2
Next Page
→